Gemopatrilat

Gemopatrilat

Names
IUPAC name [(6S)-2,2-dimethyl-7-oxo-6-{[(2S)-3-phenyl-2-sulfanylpropanoyl]amino}azepan-1-yl]acetic acid
Identifiers
3D model (Jmol)	Interactive image
ChEMBL	ChEMBL107747
ChemSpider	8061752
PubChem	9886079
UNII	MU9089C77W
InChI InChI=1S/C19H26N2O4S/c1-19(2)10-6-9-14(18(25)21(19)12-16(22)23)20-17(24)15(26)11-13-7-4-3-5-8-13/h3-5,7-8,14-15,26H,6,9-12H2,1-2H3,(H,20,24)(H,22,23)/t14-,15-/m0/s1 Key: YRSVDSQRGBYVIY-GJZGRUSLSA-N
SMILES O=C1N(CC(=O)O)C(CCC[C@@H]1NC(=O)[C@@H](S)Cc2ccccc2)(C)C
Properties
Chemical formula	C19H26N2O4S
Molar mass	378.49
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
verify (what is  ?)
Infobox references

Gemopatrilat is a drug which acts as an vasopeptidase inhibitor.^[1][2]

References

1. Laverman GD, Van Goor H, Henning RH, De Jong PE, De Zeeuw D, Navis G (January 2003). "Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes". Kidney International. 63 (1): 64–71. doi:10.1046/j.1523-1755.2003.00708.x. PMID 12472769.
2. Wait JC, Vaccharajani N, Mitroka J, Jemal M, Khan S, Bonacorsi SJ, Rinehart JK, Iyer RA (June 2006). "Metabolism of [14C]gemopatrilat after oral administration to rats, dogs, and humans". Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34 (6): 961–70. doi:10.1124/dmd.105.007500. PMID 16540589.